These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1759947)

  • 21. Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists.
    McGurk SR; Levin ED; Butcher LL
    Neuroscience; 1991; 44(1):137-47. PubMed ID: 1770993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice.
    Leblond L; Beaufort C; Delerue F; Durkin TP
    Behav Brain Res; 2002 Jan; 128(1):91-102. PubMed ID: 11755693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice.
    Yue CQ; Ye J; Li CL; Li RT; Sun Q
    Pharmacol Biochem Behav; 2007 Apr; 86(4):643-50. PubMed ID: 17379285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists.
    Stone WS; Walser B; Gold SD; Gold PE
    Behav Neurosci; 1991 Apr; 105(2):264-71. PubMed ID: 2043273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotinic-dopaminergic relationships and radial-arm maze performance in rats.
    McGurk SR; Levin ED; Butcher LL
    Behav Neural Biol; 1989 Jul; 52(1):78-86. PubMed ID: 2757586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in learning and memory in mice: effects of sequence of testing and cholinergic blockade.
    Berger-Sweeney J; Arnold A; Gabeau D; Mills J
    Behav Neurosci; 1995 Oct; 109(5):859-73. PubMed ID: 8554711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cholinergic agents on locomotor activity of P and NP rats.
    Katner SN; McBride WJ; Lumeng L; Li TK; Murphy JM
    Alcohol Clin Exp Res; 1996 Sep; 20(6):1004-10. PubMed ID: 8892519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of concurrent nicotinic antagonist and PCPA treatments on spatial and passive avoidance learning.
    Riekkinen P; Riekkinen M; Sirviö J; Riekkinen P
    Brain Res; 1992 Mar; 575(2):247-50. PubMed ID: 1533336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxiracetam prevents mecamylamine-induced impairment of active, but not passive, avoidance learning in mice.
    Sansone M; Castellano C; Battaglia M; Ammassari-Teule M
    Pharmacol Biochem Behav; 1990 Jun; 36(2):389-92. PubMed ID: 2356212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of anticholinergic drugs on delayed time discrimination performance in rats.
    Berz S; Bättig K; Welzl H
    Physiol Behav; 1992 Mar; 51(3):493-9. PubMed ID: 1523226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic antagonist.
    Baratti CM; Faiman CP; de Erausquin GA
    Behav Neural Biol; 1989 May; 51(3):424-35. PubMed ID: 2525022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice.
    Rabenstein RL; Caldarone BJ; Picciotto MR
    Psychopharmacology (Berl); 2006 Dec; 189(3):395-401. PubMed ID: 17016705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Memory improving actions of gabapentin in mice: possible involvement of central muscarinic cholinergic mechanism.
    Boccia MM; Acosta GB; Baratti CM
    Neurosci Lett; 2001 Oct; 311(3):153-6. PubMed ID: 11578817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal caused by n-butylidenephthalide from the deficits of inhibitory avoidance performance in rats.
    Hsieh MT; Wu CR; Lin LW; Hsieh CC; Tsai CH
    Planta Med; 2001 Feb; 67(1):38-42. PubMed ID: 11270720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of central cholinergic mechanisms in the effects of oxytocin and an oxytocin receptor antagonist on retention performance in mice.
    Boccia MM; Baratti CM
    Neurobiol Learn Mem; 2000 Nov; 74(3):217-28. PubMed ID: 11031128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposing influences on behavior mediated by muscarinic and nicotinic receptors in the rat posterior hypothalamic nucleus.
    Buccafusco JJ; Brezenoff HE
    Psychopharmacology (Berl); 1980; 67(3):249-54. PubMed ID: 6770404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of cholinergic system modulators on morphine state-dependent memory of passive avoidance in mice.
    Jafari MR; Zarrindast MR; Djahanguiri B
    Physiol Behav; 2006 Jun; 88(1-2):146-51. PubMed ID: 16678225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed matching-to-sample performance by rats in a new avoidance-motivated maze: response to scopolamine and fimbria-fornix lesions.
    Bresnahan EL; Wiser PR; Muth NJ; Ingram DK
    Physiol Behav; 1992 Apr; 51(4):735-46. PubMed ID: 1594672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood glucose and brain function: interactions with CNS cholinergic systems.
    Stone WS; Cottrill KL; Walker DL; Gold PE
    Behav Neural Biol; 1988 Nov; 50(3):325-34. PubMed ID: 3202815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficits in passive avoidance learning in young rats following mecamylamine injections in the hippocampo-entorhinal area.
    Blozovski D
    Exp Brain Res; 1983; 50(2-3):442-8. PubMed ID: 6641878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.